Story perspectives

Trump and Pfizer Strike Deal for Lower Drug Prices

9/30/2025

Summary

Story summary

Trump and Pfizer reached a deal to sell Medicaid medications at Europe-aligned prices, aiming to cut costs.
TrumpRx website will let Americans buy directly from manufacturers, bypassing insurance, though it may not help all insured people.
Trump said that all new Pfizer medications will be sold at most-favored-nation prices, tying U.S. costs to other wealthy nations.

History

Historical Context

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 introduced a prescription drug benefit for seniors, allowing private plans to negotiate prices. This legislation significantly impacted pharmaceutical companies like Pfizer, which reported $51.8 billion in revenue in 2020. Recent agreements, including one between Trump and Pfizer, aim to align U.S. drug prices with European standards, potentially reshaping healthcare access and affordability.

1 of 2

Story summary

Trump and Pfizer reached a deal to sell Medicaid medications at Europe-aligned prices, aiming to cut costs.
TrumpRx website will let Americans buy directly from manufacturers, bypassing insurance, though it may not help all insured people.
Trump said that all new Pfizer medications will be sold at most-favored-nation prices, tying U.S. costs to other wealthy nations.

1 / 2